dabrafenib trametinib

Details

Files

Generic Name:

Project Status:

Pending

Therapeutic Area:

Pediatric low grade glioma (ped LGG)

Call for patient/clinician input open:

October 17, 2024

Brand Name:

TBC

Project Line:

Reimbursement Review

Project Number:

PX0375-000

Call for patient/clinician input closed:

December 6, 2024

Submission Type:

Non-sponsored Submission

Indications:

in pediatric and young adult patients for 1st line or greater therapy in low grade gliomas with residual disease and with known BRAF V600 mutations.

Last Updated : October 17, 2024